Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90556603 | 9055660 | 3 | F | 20120920 | 20160830 | 20130206 | 20160831 | EXP | JP-PFIZER INC-2013037596 | PFIZER | 69.00 | YR | M | Y | 59.00000 | KG | 20160831 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90556603 | 9055660 | 1 | PS | SOMAVERT | PEGVISOMANT | 1 | Subcutaneous | 40 MG, 1X/DAY | 1618 | MG | Y | 21106 | 40 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QD | |||
| 90556603 | 9055660 | 2 | SS | SOMAVERT | PEGVISOMANT | 1 | Subcutaneous | 10 MG, 1X/DAY | 1618 | MG | Y | 21106 | 10 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QD | |||
| 90556603 | 9055660 | 3 | SS | SOMAVERT | PEGVISOMANT | 1 | Subcutaneous | 10 MG, 1X/DAY | 1618 | MG | Y | 21106 | 10 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QD | |||
| 90556603 | 9055660 | 4 | SS | SOMAVERT | PEGVISOMANT | 1 | Subcutaneous | 10 MG, ALTERNATE DAY | 1618 | MG | Y | 21106 | 10 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD | |||
| 90556603 | 9055660 | 5 | C | CABASER | CABERGOLINE | 1 | Oral | 8 MG, WEEKLY | 0 | 8 | MG | /wk | |||||||
| 90556603 | 9055660 | 6 | C | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | 40 MG, MONTHLY | 0 | 40 | MG | /month | ||||||||
| 90556603 | 9055660 | 7 | C | GASMOTIN | MOSAPRIDE CITRATE | 1 | Oral | 15 MG, 3X/DAY | 0 | 15 | MG | TID | |||||||
| 90556603 | 9055660 | 8 | C | TAKEPRON OD | LANSOPRAZOLE | 1 | Oral | 15 MG, 1X/DAY | 0 | 15 | MG | QD | |||||||
| 90556603 | 9055660 | 9 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | 0 | |||||||||||
| 90556603 | 9055660 | 10 | C | THYRADIN S | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | GRANULES | ||||||||||
| 90556603 | 9055660 | 11 | C | CORTRIL | HYDROCORTISONE | 1 | Oral | UNK | 0 | ||||||||||
| 90556603 | 9055660 | 12 | C | ALOSENN | SENNA LEAF | 1 | Oral | UNK | 0 | ||||||||||
| 90556603 | 9055660 | 13 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | UNK | 0 | ||||||||||
| 90556603 | 9055660 | 14 | C | FERROMIA | FERROUS CITRATE | 1 | Oral | UNK | 0 | ||||||||||
| 90556603 | 9055660 | 15 | C | DAI-KENCHU-TO | MALTOSE | 1 | Oral | UNK | 0 | ||||||||||
| 90556603 | 9055660 | 16 | C | GRAMALIL | TIAPRIDE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 90556603 | 9055660 | 17 | C | ROZEREM | RAMELTEON | 1 | UNK | 0 | |||||||||||
| 90556603 | 9055660 | 18 | C | MIYA-BM | CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 | 1 | Oral | UNK | 0 | ||||||||||
| 90556603 | 9055660 | 19 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | UNK | 0 | ||||||||||
| 90556603 | 9055660 | 20 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | UNK | 0 | ||||||||||
| 90556603 | 9055660 | 21 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | UNK | 0 | ||||||||||
| 90556603 | 9055660 | 22 | C | RISUMIC | AMEZINIUM METILSULFATE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 90556603 | 9055660 | 1 | Acromegaly |
| 90556603 | 9055660 | 5 | Acromegaly |
| 90556603 | 9055660 | 6 | Acromegaly |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 90556603 | 9055660 | DE |
| 90556603 | 9055660 | DS |
| 90556603 | 9055660 | HO |
| 90556603 | 9055660 | LT |
| 90556603 | 9055660 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 90556603 | 9055660 | Altered state of consciousness | |
| 90556603 | 9055660 | Cardiac failure congestive | |
| 90556603 | 9055660 | Disease progression | |
| 90556603 | 9055660 | Epilepsy | |
| 90556603 | 9055660 | Hepatic cancer metastatic | |
| 90556603 | 9055660 | Hydrocephalus | |
| 90556603 | 9055660 | Intestinal obstruction | |
| 90556603 | 9055660 | Pituitary tumour | |
| 90556603 | 9055660 | Pneumonia aspiration | |
| 90556603 | 9055660 | Respiratory failure | |
| 90556603 | 9055660 | Seizure | |
| 90556603 | 9055660 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 90556603 | 9055660 | 1 | 20120521 | 20120521 | 0 | |
| 90556603 | 9055660 | 2 | 20120522 | 20120904 | 0 | |
| 90556603 | 9055660 | 3 | 20120910 | 20121015 | 0 | |
| 90556603 | 9055660 | 4 | 20121017 | 20130125 | 0 | |
| 90556603 | 9055660 | 11 | 20121024 | 0 | ||
| 90556603 | 9055660 | 12 | 20120620 | 0 | ||
| 90556603 | 9055660 | 13 | 20121025 | 0 | ||
| 90556603 | 9055660 | 14 | 20120919 | 0 | ||
| 90556603 | 9055660 | 15 | 20120711 | 0 | ||
| 90556603 | 9055660 | 16 | 20120619 | 20120919 | 0 | |
| 90556603 | 9055660 | 17 | 20120712 | 20120803 | 0 | |
| 90556603 | 9055660 | 18 | 20120724 | 20120806 | 0 | |
| 90556603 | 9055660 | 19 | 20120726 | 20120919 | 0 | |
| 90556603 | 9055660 | 20 | 20120914 | 20120919 | 0 | |
| 90556603 | 9055660 | 21 | 20120924 | 20121003 | 0 | |
| 90556603 | 9055660 | 22 | 20121115 | 0 |